Get started
Author

Manuel Suárez Tembra

Observed names: M Suarez Tembra, M. Suarez-Tembra, M. Suárez Tembra, MANUEL SUAREZ TEMBRA, Manuel A. Suárez-Tembra, Manuel Suarez Tembra, Manuel Suarez-Tembra, Manuel Suárez-Tembra, Manuel Suárez‐Tembra, Manuel Suarez Tembra
ORCID: 0000-0001-6862-4184
Observed ORCIDs: 0000-0001-6862-4184, 0000-0002-4224-5853
OpenAlex ID: A5087980291
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
2024 · Kausik K Ray, Carlos Aguiar, et al. · European Journal of Preventive Cardiology · 95
PDF
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
2019 · Sofía Perez-Calahorra, Martín Laclaustra, et al. · Atherosclerosis · 69
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
2018 · María José Ariza, José Rioja, et al. · Journal of clinical lipidology · 46
Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population
2011 · Juan F. Ascaso, Jesús Millán, et al. · European Journal of Internal Medicine · 37
Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolaemia
2020 · Sofia Perez-Calahorra, Fernando Civeira, et al. · European Journal of Preventive Cardiology · 29
PDF
Prevalencia de obesidad según la estadificación de Edmonton en las consultas de Medicina Interna. Resultados del estudio OBEMI
2016 · J. Carretero Gómez, J.C. Arévalo Lorido, et al. · Revista Clínica Española · 23
Prevalencia de enfermedad arterial periférica asintomática, estimada mediante el índice tobillo-brazo, en pacientes con enfermedad vascular. Estudio MERITO II
2008 · José M. Mostaza, Luis Manzano, et al. · Medicina Clínica · 23
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
2017 · Luis Masana, Nuria Plana, et al. · Atherosclerosis · 21
PDF
LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry
2021 · Elisenda Climent, Ana M. Bea, et al. · Cardiovascular Drugs and Therapy · 17
PDF
Diferencias clínicas y genéticas de los pacientes con hipercolesterolemia familiar heterocigota con y sin diabetes mellitus tipo 2
2019 · Elisenda Climent, Sofía Pérez-Calahorra, et al. · Revista Española de Cardiología · 16
Screening of APOB Gene Mutations in Subjects with Clinical Diagnosis of Familial Hypercholesterolemia
2005 · Erardo Merino-Ibarra, Sergio Castillo, et al. · Human Biology · 15
Sex Disparities in Familial Hypercholesterolemia
2023 · Amanda Jiménez, Clara Viñals, et al. · Journal of the American College of Cardiology · 13
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
2024 · Victoria Marco-Benedí, Rosa M. Sánchez-Hernández, et al. · Lipids in Health and Disease · 12
PDF
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia
2021 · Elisenda Climent, Victoria Marco-Benedí, et al. · Nutrition Metabolism and Cardiovascular Diseases · 12
Consenso sobre lipoproteína (a) de la Sociedad Española de Arteriosclerosis. Revisión bibliográfica y recomendaciones para la práctica clínica
2024 · Javier Delgado-Lista, Jose M. Mostaza, et al. · Clínica e Investigación en Arteriosclerosis · 11
Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes
2019 · Elisenda Climent, Sofía Pérez-Calahorra, et al. · Revista Española de Cardiología (English Edition) · 11
Criterios de derivación para pacientes a las unidades de lípidos de la Sociedad Española de Arteriosclerosis
2018 · Miguel Ángel Sánchez-Chaparro, Pablo Pérez-Martínez, et al. · Clínica e Investigación en Arteriosclerosis · 11
Prevalence of obesity according to Edmonton staging in the Internal Medicine consultations. Results of the OBEMI study
2017 · J. Carretero Gómez, J.C. Arévalo Lorido, et al. · Revista Clínica Española (English Edition) · 11
SEA-SEACV 2015: Guía para el diagnóstico y tratamiento del aneurisma de aorta abdominal
2016 · Carlos Lahoz, Carlos Esteban Gracia, et al. · Clínica e Investigación en Arteriosclerosis · 11
Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study
2021 · Ferran Trias, Xavier Pintó, et al. · Medicina Clínica · 10
Maternally inherited hypercholesterolemia does not modify the cardiovascular phenotype in familial hypercholesterolemia
2021 · Victoria Marco-Benedí, Martín Laclaustra, et al. · Atherosclerosis · 10
Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
2024 · Javier Delgado-Lista, Jose M. Mostaza, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 9
Criteria for referring patients to Spanish Atherosclerosis Society lipid units
2019 · Miguel Ángel Sánchez-Chaparro, Pablo Pérez-Martínez, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 9
Recomendaciones de la guía para el diagnóstico y tratamiento del aneurisma de aorta abdominal
2015 · Carlos Lahoz, Carlos Esteban Gracia, et al. · Clínica e Investigación en Arteriosclerosis · 9
Prognostic stratification of familial hypercholesterolaemia patients using AI algorithms: a gender-specific approach
2025 · Alberto Zamora, Luis Masana, et al. · European Heart Journal - Digital Health · 8
PDF
Works count: 53
Citation count: 588
H-index: 12
I10-index: 21
Year
Topic
Type